Curculigoside
Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.
Product Specifications
CAS Number
85643-19-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
466.43
Molecular Formula
C22H26O11
Notes
Research use only, not for human use.
Receptor
Antioxidant
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog